AstraZeneca looking for strong Japan debut for Symbicort
This article was originally published in Scrip
Executive Summary
AstraZeneca and Astellas are looking to win a market leading position for Symbicort in Japan, where more sales reps than in any other country are promoting the inhaled combination asthma product following its launch this week.